**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 14268-66-7 |3,4-(Methylenedioxy)aniline | 97 | 238-161-6 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 20/21
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation and in contact with skin.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis and
corneal damage.
Skin:
Causes skin irritation. Absorption into the body may cause cyanosis
(bluish discoloration of skin due to deficient oxygenation of the
blood).
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. May cause liver and kidney damage. Methemoglobinemia is
characterized by dizziness, drowsiness, headache, shortness of
breath, cyanosis (bluish discoloration of skin due to deficient
oxygenation of the blood), rapid heart rate and chocolate-brown
colored blood. Overexposure may cause methemoglobinemia.
Inhalation:
Causes respiratory tract irritation. May cause liver and kidney
damage. Methemoglobinemia is characterized by dizziness, drowsiness,
headache, shortness of breath, cyanosis (bluish discoloration of skin
due to deficient oxygenation of the blood), rapid heart rate and
chocolate-brown blood. Can produce delayed pulmonary edema.
Inhalation of aniline causes anoxia due to the formation of
methemoglobin.
Chronic:
May cause liver and kidney damage. May cause methemoglobinemia,
which is characterized by chocolate-brown colored blood, headache,
weakness, dizziness, breath shortness, cyanosis (bluish skin due to
deficient oxygenation of blood), rapid heart rate, unconsciousness
and possible death. Effects may be delayed.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid. Do NOT use mouth-to-mouth
resuscitation.
Notes to Physician:
For methemoglobinemia, administer oxygen alone or with Methylene
Blue depending on the methemoglobin concentration in the blood. Treat
symptomatically and supportively.
Antidote:
Methylene blue, alone or in combination with oxygen is indicated as
a treatment in nitrite induced methemoglobinemia.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Sweep up, then place into a suitable container for disposal. Avoid
generating dusty conditions. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Minimize dust generation and accumulation. Avoid
contact with eyes, skin, and clothing. Avoid ingestion and
inhalation. Use with adequate ventilation.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 14268-66-7:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Color: after melting, very dark brown
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 144 deg C @ 16.00mmHg
Freezing/Melting Point: 39.00 - 41.00 deg C
Autoignition Temperature: Not applicable.
Flash Point: 142 deg C ( 287.60 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: slightly soluble
Specific Gravity/Density: Not available.
Molecular Formula: C7H7NO2
Molecular Weight: 137.14
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions. May discolor on exposure to air and light.
Conditions to Avoid:
Incompatible materials, dust generation, exposure to air, excess
heat, excess light.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong acids, acid chlorides, acid
anhydrides, air, direct light.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide, nitrogen, ammonia.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 14268-66-7 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
3,4-(Methylenedioxy)aniline -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing group: III
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21 Harmful by inhalation and in contact with
skin.
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 14268-66-7: No information available.
Canada
CAS# 14268-66-7 is listed on Canada's NDSL List.
CAS# 14268-66-7 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 14268-66-7 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #4 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
l-Cysteic Acid Monohydrate, 99+%
| 23537-25-9 |
|
1-Hexanesulfonic acid sodium salt premixed concentrate
| |
|
N-Alpha-Carbobenzyloxy-L-Asparagine, 98%
| 2304-96-3 |
|
Ytterbium atomic absorption standard solution, 1 mg/ml yb in 2% hno3
| |
|
Bromotrichloromethane, 99%
| 75-62-7 |
|
Dicyclopentadiene, 95%, stabilized with 100-200 ppm
| 77-73-6 |
|
3-Amino-1-propanesulfonic acid, 95%
| 3687-18-1 |
|
Copper(ii) fluoride, anhydrous, 99+%
| 7789-19-7 |
|
2-Chloro-4-Fluorophenylacetic Acid
| 177985-32-9 |
|
Cyclopropyl Phenyl Sulfide
| 14633-54-6 |
|
BOC-L-Tyrosine, 99+%
| 3978-80-1 |
|
1,8-Octanediol, 99+%
| 629-41-4 |
|
3-Thiophenecarboxylic acid, 99%
| 88-13-1 |
|
1,2,3-Trimethylbenzene, Tech., 90%
| 526-73-8 |
|
Molybdenum(v) chloride, 98%
| 10241-05-1 |
|
2-Dimethylaminoethyl Acetate
| 1421-89-2 |
|
4-Benzyl-4-Hydroxypiperidine, 95+%(GC)
| 51135-96-7 |
|
8-Chloroquinoline, 99% (gc)
| 611-33-6 |
|
2-Ethyl-3,5(6)-dimethylpyrazine,99.5+%
| 27043-05-6 |
|
p-Ethoxybenzyl Alcohol, 98%
| 6214-44-4 |
|
2,3-Dichlorothiophene, 97%
| 17249-79-5 |
|
Tropolone, 98%
| 533-75-5 |
|
1,3-Difluorobenzene, 99+%
| 372-18-9 |
|
2-Methylundecanal, 95%
| 110-41-8 |
|
2-Ethyl-2-methyl-1,3-dioxolane, 99%
| 126-39-6 |
|
Bromoethane, 98%
| 74-96-4 |
|
1,3,5-Triphenylbenzene, 97%
| 612-71-5 |
|
1-Tetradecene, 92%
| 1120-36-1 |
|
9,10-Anthracenedicarboxaldehyde, 95% (UV-Vis)
| 7044-91-9 |
|
Lead cyclohexanebutyrate
| 62637-99-4 |
|
1-Butanethiol, 99+%
| 109-79-5 |
|
L-(+)-Homoarginine hydrochloride, 99+%
| 1483-01-8 |
|
3,4-(Methylenedioxy)-aniline, 97%
| 14268-66-7 |
|
(2-Chloroethyl)benzene, 99%
| 622-24-2 |
|
Poly(propylene), chlorinated
| 68442-33-1 |
|
Dodecyl aldehyde, 96%, stabilized with 0.1% BHA
| 112-54-9 |
|
N,N'-Diallyltartardiamide
| 58477-85-3 |
|
5,6,7,8-Tetrahydro-2-naphthol, 98%
| 1125-78-6 |
|
Cyclodecanone, 97%
| 1502-06-3 |
|
4-Amino-1-butanol, 98%
| 13325-10-5 |
|
4-Aminoveratrole, 98%
| 6315-89-5 |
|
2-Bromo-4-nitrotoluene, 98%
| 7745-93-9 |
|
Pulegone (Pract), 88% (GC)
| 89-82-7 |
|
Diethyl suberate, 98%
| 2050-23-9 |
|
beta-Bromostyrene, mixture of cis/trans isomers, 97%
| 103-64-0 |
|
Naphthenic acids (pract)
| 1338-24-5 |
|
S(+)-1,3-Butanediol, 98%
| 24621-61-2 |
|
5-Bromo-1,2,4-trimethylbenzene, 99%
| 5469-19-2 |
|
alpha-D(+)-Melibiose hydrate, 99+%
| 585-99-9 |
|
O-Tolualdehyde 98% (Stabilized with 0.1 % H.Q.)
| 529-20-4 |
|
|